Letters to the Editor
ADHD and IQ Testing
FREE PREVIEW Log in or buy this issue to read the full article. AAFP members and paid subscribers get free access to all articles. Subscribe now.
FREE PREVIEW Subscribe or buy this issue. AAFP members and paid subscribers get free access to all articles.
Am Fam Physician. 2002 Jun 15;65(12) Online.
to the editor: In response to the article "Attention-Deficit/Hyperactivity Disorder: Management,"1 by Drs. Szymanski and Zolotor, I would recommend that readers consider intelligence in the differential diagnosis. I have started ordering IQ testing on select patients and have found a fair number of geniuses among this population who would otherwise meet the criteria for treatment. These children, some of whom have IQs greater than the average physician’s IQ of 126, are not challenged by repetitive curricula and need additional and more complex assignments to hold their interest. They should also be placed with the best teachers because many can outsmart their adult instructors.
1. Szymanski ML, Zolotor A. Attention-deficit/hyperactivity disorder: management. Am Fam Physician 2001;64:1355-62.
in reply: Dr. Woodhouse's point is well taken. However, I would not advocate routine IQ testing for all patients evaluated with attention-deficit disorder (ADD). I agree that for a select group of patients, IQ testing may reveal the bored, yet unrecognized genius, who would likely be better served by changes in the learning environment. Nevertheless, keep in mind that intelligence and attention deficits are thought to be independent factors that influence ones ability to function academically and interpersonally. A diagnosis of ADD does not indicate a low IQ, and a high IQ does not eliminate the potential existence of attention deficits. The decision to intervene in whatever fashion (e.g., medication, further neuropsychological evaluation, change of academic/work environment, counseling) is complex; this decision should be influenced by the quality and severity of initial dysfunctional behavior and academic difficulty. Further evaluation should definitely be considered before medication is prescribed in patients where there is a significant discrepancy in the observations of different persons or when the patient is in different settings. Similarly, if a medication trial fails to meet treatment goals, further evaluation might turn up a common comorbidity (e.g., depression, sleep disorder, hyperfocused/compulsive, aggressive/oppositional) as well as the learning disabled or the emotionally impaired student.
Send letters to Kenneth W. Lin, MD, MPH, Associate Deputy Editor for AFP Online, e-mail: firstname.lastname@example.org, or 11400 Tomahawk Creek Pkwy., Leawood, KS 66211-2680.
Please include your complete address, e-mail address, and telephone number. Letters should be fewer than 400 words and limited to six references, one table or figure, and three authors.
Letters submitted for publication in AFP must not be submitted to any other publication. Possible conflicts of interest must be disclosed at time of submission. Submission of a letter will be construed as granting the American Academy of Family Physicians permission to publish the letter in any of its publications in any form. The editors may edit letters to meet style and space requirements.
Copyright © 2002 by the American Academy of Family Physicians.
This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. Contact email@example.com for copyright questions and/or permission requests.
Want to use this article elsewhere? Get Permissions